Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart

FASEB Journal

Volumn 18, Issue 14, 2004, Pages 1692-1700

  Sharma, Saumya ^a   Adrogue, Julia V ^a   Golfman, Leonard ^a   Uray, Ivan ^a   Lemm, John ^a   Youker, Keith ^b   Noon, George P ^b   Frazier, O H ^c   Taegtmeyer, Heinrich ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Contractile dysfunction; Lipotoxicity; Non ischemic heart failure; Triglyceride accumulation

Indexed keywords

MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RAT STRAIN; STAINING; UPREGULATION;

ADULT; AGED; ANIMALS; CARDIAC OUTPUT, LOW; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOSINS; OBESITY; RATS; RATS, ZUCKER; SARCOMERES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 7744234747     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2263com     Document Type: Article

References (35)

1. Kelly, D. P., Hale, D. E., Rutledge, S. L., Ogden, M. L., Whelan, A. J., Zhang, Z., and Strauss, A. W. (1992) Molecular basis of inherited medium-chain acyl-CoA dehydrogenase deficiency causing sudden child death. J. Inherit. Metab. Dis. 15, 171-180
2. Unger, R. H. (2003) The physiology of cellular liporegulation. Annu. Rev. Physiol. 65, 333-347
3. Young, M. E., Guthrie, P. H., Razeghi, P., Leighton, B., Abbasi, S., Patil, S., and Taegtmeyer, H. (2002) Impaired long chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51, 2587-2595
4. Zhou, Y. T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., and Unger, R. H. (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA 97, 1784-1789
5. Barger, P. M., and Kelly, D. P. (2000) PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc. Med. 10, 238-245
6. Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J., Kovacs, A., Gross, R. W., and Kelly, D. P. (2003) A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. USA 100, 1226-1231
7. Young, M. E., Laws, F. A., Goodwin, G. W., and Taegtmeyer, H. (2001) Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J. Biol. Chem. 276, 44390-44395
8. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415
9. Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., and Simsolo, R. B. (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111-2119
10. Mann, D. L. (2002) Tumor necrosis factor-induced signal transduction and left ventricular remodeling. J. Card. Fail. 8, S379-S386
11. Listenberger, L. L., and Schaffer, J. E. (2002) Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc. Med. 12, 134-138
12. Taegtmeyer, H., Hems, R., and Krebs, H. A. (1980) Utilization of energy providing substrates in the isolated working rat heart. Biochem. J. 186, 701-711
13. Goodwin, G. W., Taylor, C. S., and Taegtmeyer, H. (1998) Regulation of energy metabolism of the heart during acute increase in heart work. J. Biol. Chem. 273, 29530-29539
14. Depre, C., Shipley, G. L., Chen, W., Han, Q., Doenst, T., Moore, M. L., Stepkowski, S., Davies, P. J. A., and Taegtmeyer, H. (1998) Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat. Med. 4, 1269-1275
15. Razeghi, P., Young, M. E., Alcorn, J. L., Moravec, C. S., Frazier, O. H., and Taegtmeyer, H. (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104, 2923-2931
16. Razeghi, P., Sharma, S., Ying, J., Li, Y. P., Stepkowski, S., Reid, M. B., and Taegtmeyer, H. (2003) Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 108, 2536-2541
17. Sack, M. N., Rader, T. A., Park, S., Bastin, J., McCune, S. A., and Kelly, D. P. (1996) Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94, 2837-2842
18. Holubarsch, C., Goulette, R. P., Litten, R. Z., Martin, B. J., Mulieri, L. A., and Alpert, N. R. (1985) The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ. Res. 56, 78-86
19. Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., and Feldman, A. M. (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ. Res. 81, 627-635
20. Sivasubramanian, N., Coker, M. L., Kurrelmeyer, K. M., MacLellan, W. R., DeMayo, F. J., Spinale, F. G., and Mann, D. L. (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104, 826-831
21. Taegtmeyer, H. (1994) Energy metabolism of the heart: from basic concepts to clinical applications. Curr. Prob. Cardiol. 19, 57-116
22. Chiu, H. C., Kovacs, A., Ford, D. A., Hsu, F. F., Garcia, R., Herrero, P., Saffitz, J. E., and Schaffer, J. E. (2001) A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107, 813-822
23. Cooney, G. J., Thompson, A. L., Furler, S. M., Ye, J., and Kraegen, E. W. (2002) Muscle long-chain acyl CoA esters and insulin resistance. Ann. N.Y. Acad. Sci. 967, 196-207
24. Boden, G. (2004) Fatty acids and insulin resistance. In Diabetes Mellitus: A Fundamental and Clinical Text (LeRoith, D., Taylor, S. I., and Olefsky, J. M., eds) pp. 979-986, Lippincott Williams and Wilkins, New York
25. Stein, D. T. (2004) Triglyceride in muscle. In Diabetes Mellitus: A Fundamental and Clinical Text (LeRoith, D., Taylor, S. I., and Olefsky, J. M., eds) pp. 987-1002, Lippincott Williams and Wilkins, New York
26. Paolisso, G., De Riu, S., Marrazzo, G., Verza, M., Varricchio, M., and D'Onofrio, F. (1991) Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 40, 972-977
27. Nikolaidis, L. A., Sturzu, A., Stolarski, C., Elahi, D., Shen, Y. T., and Shannon, R. P. (2004) The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc. Res. 61, 297-306
28. Miyata, S., Minobe, W., Bristow, M., and Leinwand, L. (2000) Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86, 386-390
29. Swynghedauw, B. (1986) Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol. Rev. 66, 710-771
30. Tardiff, J. C., Hewett, T. E., Factor, S. M., Vikstrom, K. L., Robbins, J., and Leinwand, L. A. (2000) Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am. J. Physiol. 278, H412-H419
31. Rupp, H., Schulze, W., and Vetter, R. (1995) Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir. Am. J. Physiol. 269, R630-R640
32. Razeghi, P., Young, M. E., Cockrill, T. C., Frazier, O. H., and Taegtmeyer, H. (2002) Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with non-ischemic heart failure. Circulation 106, 407-411
33. Czubryt, M. P., McNally, J., Fishman, G. I., and Olson, E. N. (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA 100, 1711-1716
34. Hotamisligil, G. S. (2004) Inflammation, tumor necrosis factor alpha, and insulin resistance. In Diabetes Mellitus: A Fundamental and Clinical Text (LeRoith, D., Taylor, S. I., and Olefsky, J. M., eds) pp. 953-962, Lippincott Williams and Wilkins, New York
35. Suffredini, A. F., Fromm, R. E., Parker, M. M., Brenner, M., Kovacs, J. A., Wesley, R. A., and Parrillo, J. E. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321, 1828-1830